PMID- 33079174 OWN - NLM STAT- MEDLINE DCOM- 20211019 LR - 20211019 IS - 1945-7197 (Electronic) IS - 0021-972X (Linking) VI - 106 IP - 4 DP - 2021 Mar 25 TI - Elevated Plasma Branched-Chain Amino Acid Levels Correlate With Type 2 Diabetes-Related Metabolic Disturbances. PG - e1827-e1836 LID - 10.1210/clinem/dgaa751 [doi] AB - CONTEXT: Patients with type 2 diabetes mellitus (T2DM) have elevated plasma branched-chain amino acid (BCAA) levels. The underlying cause, however, is not known. Low mitochondrial oxidation of BCAA levels could contribute to higher plasma BCAA levels. OBJECTIVE: We aimed to investigate ex vivo muscle mitochondrial oxidative capacity and in vivo BCAA oxidation measured by whole-body leucine oxidation rates in patients with T2DM, first-degree relatives (FDRs), and control participants (CONs) with overweight or obesity. DESIGN AND SETTING: An observational, community-based study was conducted. PARTICIPANTS: Fifteen patients with T2DM, 13 FDR, and 17 CONs were included (age, 40-70 years; body mass index, 27-35 kg/m2). MAIN OUTCOME MEASURES: High-resolution respirometry was used to examine ex vivo mitochondrial oxidative capacity in permeabilized muscle fibers. A subgroup of 5 T2DM patients and 5 CONs underwent hyperinsulinemic-euglycemic clamps combined with 1-13C leucine-infusion to determine whole-body leucine oxidation. RESULTS: Total BCAA levels were higher in patients with T2DM compared to CONs, but not in FDRs, and correlated negatively with muscle mitochondrial oxidative capacity (r = -0.44, P < .001). Consistently, whole-body leucine oxidation rate was lower in patients with T2DM vs CON under basal conditions (0.202 +/- 0.049 vs 0.275 +/- 0.043 mumol kg-1 min-1, P < .05) and tended to be lower during high insulin infusion (0.326 +/- 0.024 vs 0.382 +/- 0.013 mumol kg-1 min-1, P = .075). CONCLUSIONS: In patients with T2DM, a compromised whole-body leucine oxidation rate supports our hypothesis that higher plasma BCAA levels may originate at least partly from a low mitochondrial oxidative capacity. CI - (c) The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. FAU - Vanweert, Froukje AU - Vanweert F AD - Department of Nutrition and Movement Sciences, Maastricht University and Medical Center, Maastricht, the Netherlands. AD - NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University and Medical Center, Maastricht, the Netherlands. FAU - de Ligt, Marlies AU - de Ligt M AD - Department of Nutrition and Movement Sciences, Maastricht University and Medical Center, Maastricht, the Netherlands. AD - NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University and Medical Center, Maastricht, the Netherlands. FAU - Hoeks, Joris AU - Hoeks J AD - Department of Nutrition and Movement Sciences, Maastricht University and Medical Center, Maastricht, the Netherlands. AD - NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University and Medical Center, Maastricht, the Netherlands. FAU - Hesselink, Matthijs K C AU - Hesselink MKC AD - Department of Nutrition and Movement Sciences, Maastricht University and Medical Center, Maastricht, the Netherlands. AD - NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University and Medical Center, Maastricht, the Netherlands. FAU - Schrauwen, Patrick AU - Schrauwen P AD - Department of Nutrition and Movement Sciences, Maastricht University and Medical Center, Maastricht, the Netherlands. AD - NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University and Medical Center, Maastricht, the Netherlands. FAU - Phielix, Esther AU - Phielix E AD - Department of Nutrition and Movement Sciences, Maastricht University and Medical Center, Maastricht, the Netherlands. AD - NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University and Medical Center, Maastricht, the Netherlands. LA - eng SI - NTR/NTR4181 PT - Journal Article PT - Observational Study PT - Research Support, Non-U.S. Gov't PL - United States TA - J Clin Endocrinol Metab JT - The Journal of clinical endocrinology and metabolism JID - 0375362 RN - 0 (Amino Acids, Branched-Chain) RN - GMW67QNF9C (Leucine) SB - IM MH - Adult MH - Aged MH - Amino Acids, Branched-Chain/*blood MH - Case-Control Studies MH - Diabetes Complications/blood/diagnosis/metabolism MH - Diabetes Mellitus, Type 2/*blood/complications/metabolism MH - Female MH - Humans MH - Insulin Resistance/physiology MH - Leucine/metabolism MH - Male MH - Metabolic Diseases/*blood/diagnosis/etiology MH - Middle Aged MH - Mitochondria/metabolism MH - Oxidation-Reduction OTO - NOTNLM OT - 1-13C leucine oxidation OT - branched-chain amino acids OT - first-degree relatives OT - insulin resistance OT - mitochondrial oxidative capacity OT - type 2 diabetes EDAT- 2020/10/21 06:00 MHDA- 2021/10/21 06:00 CRDT- 2020/10/20 12:12 PHST- 2020/08/08 00:00 [received] PHST- 2020/10/14 00:00 [accepted] PHST- 2020/10/21 06:00 [pubmed] PHST- 2021/10/21 06:00 [medline] PHST- 2020/10/20 12:12 [entrez] AID - 5932347 [pii] AID - 10.1210/clinem/dgaa751 [doi] PST - ppublish SO - J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1827-e1836. doi: 10.1210/clinem/dgaa751.